[Bone marrow pathology of myeloproliferative neoplasms]

Masafumi Ito1

  • 1Department of Pathology, Japanese Red Cross, Nagoya First Hospital.

Insights

This study proposes a new algorithm for classifying myeloproliferative neoplasms (MPN) based on bone marrow histology. Specific histological features can indicate underlying genetic abnormalities, paving the way for genotype-driven MPN classification.

Area of Science:

  • Hematology
  • Oncology
  • Genetics

Context:

  • Myeloproliferative neoplasms (MPN) are a group of cancers characterized by the overproduction of myeloid cells.
  • Current MPN classification relies on clinical and histological patterns.
  • Genomic abnormalities like JAK2, MPL, and CALR mutations are key drivers in MPN pathogenesis.

Purpose:

  • To propose a novel algorithm for MPN diagnosis and classification.
  • To correlate specific bone marrow histological findings with underlying genetic abnormalities.
  • To explore the potential of a genotype-based classification system for MPN.

Summary:

  • The study focuses on identifying specific bone marrow histological features, including cellularity, erythroid islet formation, megakaryocyte morphology, and distribution.
  • These histological patterns are investigated for their association with known genetic mutations (JAK2, MPL, CALR) in MPN.
  • An algorithm is proposed to integrate histological data for improved MPN diagnosis and subclassification.

Impact:

  • This research could lead to a more precise and genotype-driven classification of MPN.
  • The proposed histological algorithm may enhance diagnostic accuracy and guide targeted therapies.
  • Facilitates a deeper understanding of the genotype-phenotype correlations in myeloproliferative neoplasms.

Related Concept Videos

Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
4.2K
Disorders of Leukocytes01:27

Disorders of Leukocytes

Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
2.4K
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K
Production of Formed Elements01:34

Production of Formed Elements

Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
6.0K
Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
4.6K
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
9.9K